Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behnam Nabet

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of a Pyrimidothiazolodiazepinone as a Potent and Selective Focal Adhesion Kinase (FAK) InhibitorBrian J Groendyke, Behnam Nabet, Mikaela L Mohardt, et al.
Cell Reports|August 18, 2015
Deregulation of the Ras-Erk Signaling Axis Modulates the Enhancer LandscapeBehnam Nabet, Pilib Ó Broin, Jaime M Reyes, et al.
Blood Advances|November 7, 2022
Chemical degradation of BTK/TEC as a novel approach to inhibit platelet functionJustin S Trory, Attila Munkacsi, Kamila M Śledź, et al.
European Journal of Medicinal Chemistry|May 21, 2022
Synthesis and Structure-Activity relationships of cyclin-dependent kinase 11 inhibitors based on a diaminothiazole scaffoldZhengnian Li, Ryosuke Ishida, Yan Liu, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Rapid-kinetics degron benchmarking reveals off-target activities and mixed agonism-antagonism of MYB inhibitorsTaku Harada, Monika W Perez, Jérémie Kalfon, et al.
Nature Communications|September 19, 2020
Rapid and direct control of target protein levels with VHL-recruiting dTAG moleculesBehnam Nabet, Fleur M Ferguson, Bo Kyung A Seong, et al.
The Journal of Biological Chemistry|October 18, 2012
Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responsesBhumika Sharma, Sonali Joshi, Antonella Sassano, et al.
Cell Chemical Biology|July 15, 2022
Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cellsStuti Mehta, Altantsetseg Buyanbat, Yan Kai, et al.
Cancer Cell|September 12, 2018
Mutant NPM1 Maintains the Leukemic State through HOX ExpressionLorenzo Brunetti, Michael C Gundry, Daniele Sorcini, et al.
Nature Genetics|June 3, 2020
Selective Mediator dependence of cell-type-specifying transcriptionMartin G Jaeger, Björn Schwalb, Sebastian D Mackowiak, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of a Pyrimidothiazolodiazepinone as a Potent and Selective Focal Adhesion Kinase (FAK) InhibitorBrian J Groendyke, Behnam Nabet, Mikaela L Mohardt, et al.
Cell Reports|August 18, 2015
Deregulation of the Ras-Erk Signaling Axis Modulates the Enhancer LandscapeBehnam Nabet, Pilib Ó Broin, Jaime M Reyes, et al.
Blood Advances|November 7, 2022
Chemical degradation of BTK/TEC as a novel approach to inhibit platelet functionJustin S Trory, Attila Munkacsi, Kamila M Śledź, et al.
European Journal of Medicinal Chemistry|May 21, 2022
Synthesis and Structure-Activity relationships of cyclin-dependent kinase 11 inhibitors based on a diaminothiazole scaffoldZhengnian Li, Ryosuke Ishida, Yan Liu, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Rapid-kinetics degron benchmarking reveals off-target activities and mixed agonism-antagonism of MYB inhibitorsTaku Harada, Monika W Perez, Jérémie Kalfon, et al.
Nature Communications|September 19, 2020
Rapid and direct control of target protein levels with VHL-recruiting dTAG moleculesBehnam Nabet, Fleur M Ferguson, Bo Kyung A Seong, et al.
The Journal of Biological Chemistry|October 18, 2012
Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responsesBhumika Sharma, Sonali Joshi, Antonella Sassano, et al.
Cell Chemical Biology|July 15, 2022
Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cellsStuti Mehta, Altantsetseg Buyanbat, Yan Kai, et al.
Cancer Cell|September 12, 2018
Mutant NPM1 Maintains the Leukemic State through HOX ExpressionLorenzo Brunetti, Michael C Gundry, Daniele Sorcini, et al.
Nature Genetics|June 3, 2020
Selective Mediator dependence of cell-type-specifying transcriptionMartin G Jaeger, Björn Schwalb, Sebastian D Mackowiak, et al.
Pageof 6